In the present study, a targeted treatment platform containing AuNPs as a carrier, FOXM1 Apt, AS1411, and ATP Apt was developed to treat breast cancer by co-delivery of Dox as a chemotherapy drug and FOXM1 Apt as a therapeutic aptamer to cancerous cells. This evidence concerns the gene FOXM1 and breast cancer.